These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 9864434

  • 1. Analysis of the cyclin-dependent kinase inhibitor p27Kip1 in muscle invasive bladder cancer.
    Serth J, Kuczyk M, Machtens S, Bokemeyer C, Herrmann R, Hartmann J, Knüchel R, Jonas U.
    Oncol Rep; 1999; 6(1):229-33. PubMed ID: 9864434
    [Abstract] [Full Text] [Related]

  • 2. Prognostic value of p27Kip1 and p21WAF/Cip protein expression in muscle invasive bladder cancer.
    Kuczyk MA, Machtens S, Bokemeyer C, Hradil K, Macheel I, Jetscho V, Hartmann J, Thon WF, Jonas U, Serth J.
    Oncol Rep; 1999; 6(3):687-93. PubMed ID: 10203616
    [Abstract] [Full Text] [Related]

  • 3. Loss of P27Kip1 expression correlates with tumor grade and with reduced disease-free survival in primary superficial bladder cancers.
    Sgambato A, Migaldi M, Faraglia B, Garagnani L, Romano G, De Gaetani C, Ferrari P, Capelli G, Trentini GP, Cittadini A.
    Cancer Res; 1999 Jul 01; 59(13):3245-50. PubMed ID: 10397272
    [Abstract] [Full Text] [Related]

  • 4. Cell cycle regulators in bladder cancer: a multivariate survival study with emphasis on p27Kip1.
    Korkolopoulou P, Christodoulou P, Konstantinidou AE, Thomas-Tsagli E, Kapralos P, Davaris P.
    Hum Pathol; 2000 Jun 01; 31(6):751-60. PubMed ID: 10872671
    [Abstract] [Full Text] [Related]

  • 5. Predictive value of decreased p27Kip1 protein expression for the recurrence-free and long-term survival of prostate cancer patients.
    Kuczyk M, Machtens S, Hradil K, Schubach J, Christian W, Knüchel R, Hartmann J, Bokemeyer C, Jonas U, Serth J.
    Br J Cancer; 1999 Nov 01; 81(6):1052-8. PubMed ID: 10576664
    [Abstract] [Full Text] [Related]

  • 6. Predictive value of altered p27Kip1 and p21WAF/Cip1 protein expression for the clinical prognosis of patients with localized prostate cancer.
    Kuczyk MA, Bokemeyer C, Hartmann J, Schubach J, Walter C, Machtens S, Knuchel R, Kollmannsberger C, Jonas U, Serth J.
    Oncol Rep; 2001 Nov 01; 8(6):1401-7. PubMed ID: 11605074
    [Abstract] [Full Text] [Related]

  • 7. Reduced expression of p27Kip1 protein is associated with poor clinical outcome of breast cancer patients treated with systemic chemotherapy and is linked to cell proliferation and differentiation.
    Han S, Park K, Kim HY, Lee MS, Kim HJ, Kim YD.
    Breast Cancer Res Treat; 1999 May 01; 55(2):161-7. PubMed ID: 10481943
    [Abstract] [Full Text] [Related]

  • 8. Paradoxical correlations of cyclin-dependent kinase inhibitors p21waf1/cip1 and p27kip1 in metastatic colorectal carcinoma.
    Cheng JD, Werness BA, Babb JS, Meropol NJ.
    Clin Cancer Res; 1999 May 01; 5(5):1057-62. PubMed ID: 10353738
    [Abstract] [Full Text] [Related]

  • 9. Loss of p21Waf1 expression is a strong predictor of reduced survival in primary superficial bladder cancers.
    Migaldi M, Sgambato A, Garagnani L, Ardito R, Ferrari P, De Gaetani C, Cittadini A, Trentini GP.
    Clin Cancer Res; 2000 Aug 01; 6(8):3131-8. PubMed ID: 10955794
    [Abstract] [Full Text] [Related]

  • 10. Loss of cyclin-dependent kinase inhibitor genes and chromosome 9 karyotypic abnormalities in human bladder cancer cell lines.
    Southgate J, Proffitt J, Roberts P, Smith B, Selby P.
    Br J Cancer; 1995 Nov 01; 72(5):1214-8. PubMed ID: 7577470
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Impact of the expression of cyclin-dependent kinase inhibitor p27Kip1 and apoptosis in tumor cells on the overall survival of patients with non-early stage gastric carcinoma.
    Ohtani M, Isozaki H, Fujii K, Nomura E, Niki M, Mabuchi H, Nishiguchi K, Toyoda M, Ishibashi T, Tanigawa N.
    Cancer; 1999 Apr 15; 85(8):1711-8. PubMed ID: 10223564
    [Abstract] [Full Text] [Related]

  • 13. Loss of cyclin-dependent kinase inhibitor p27Kip1 is a novel prognostic factor in localized human prostate adenocarcinoma.
    Tsihlias J, Kapusta LR, DeBoer G, Morava-Protzner I, Zbieranowski I, Bhattacharya N, Catzavelos GC, Klotz LH, Slingerland JM.
    Cancer Res; 1998 Feb 01; 58(3):542-8. PubMed ID: 9458103
    [Abstract] [Full Text] [Related]

  • 14. Involvement of p27Kip1 in the G1- and S/G2-phase lengthening mediated by glucocorticoids in normal human lymphocytes.
    Baghdassarian N, Peiretti A, Devaux E, Bryon PA, Ffrench M.
    Cell Growth Differ; 1999 Jun 01; 10(6):405-12. PubMed ID: 10392902
    [Abstract] [Full Text] [Related]

  • 15. TGF-beta 1 induces the cyclin-dependent kinase inhibitor p27Kip1 mRNA and protein in murine B cells.
    Kamesaki H, Nishizawa K, Michaud GY, Cossman J, Kiyono T.
    J Immunol; 1998 Jan 15; 160(2):770-7. PubMed ID: 9551912
    [Abstract] [Full Text] [Related]

  • 16. Reduced expression of the CDK inhibitor p27(KIP1) in rat two-stage bladder carcinogenesis and its association with expression profiles of p21(WAF1/Cip1) and p53.
    Lee CC, Ichihara T, Yamamoto S, Wanibuchi H, Sugimura K, Wada S, Kishimoto T, Fukushima S.
    Carcinogenesis; 1999 Sep 15; 20(9):1697-708. PubMed ID: 10469613
    [Abstract] [Full Text] [Related]

  • 17. Loss of heterozygosity in the chromosomal region 12p12-13 is very common in childhood acute lymphoblastic leukemia and permits the precise localization of a tumor-suppressor gene distinct from p27KIP1.
    Cavé H, Gérard B, Martin E, Guidal C, Devaux I, Weissenbach J, Elion J, Vilmer E, Grandchamp B.
    Blood; 1995 Nov 15; 86(10):3869-75. PubMed ID: 7579355
    [Abstract] [Full Text] [Related]

  • 18. Antiproliferative function of p27kip1 is frequently inhibited in highly malignant Burkitt's lymphoma cells.
    Barnouin K, Fredersdorf S, Eddaoudi A, Mittnacht S, Pan LX, Du MQ, Lu X.
    Oncogene; 1999 Nov 04; 18(46):6388-97. PubMed ID: 10597239
    [Abstract] [Full Text] [Related]

  • 19. p27Kip1 is the key mediator of phenylacetate induced cell cycle arrest in human prostate cancer cells.
    Onishi T, Yamakawa K, Franco OE, Suzuki R, Kawamura J.
    Anticancer Res; 2000 Nov 04; 20(5A):3075-81. PubMed ID: 11062725
    [Abstract] [Full Text] [Related]

  • 20. High glucose-induced hypertrophy of mesangial cells requires p27(Kip1), an inhibitor of cyclin-dependent kinases.
    Wolf G, Schroeder R, Zahner G, Stahl RA, Shankland SJ.
    Am J Pathol; 2001 Mar 04; 158(3):1091-100. PubMed ID: 11238057
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.